Royalty Pharma plc (RPRX) Financials

RPRX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 19.8 billion 9.9 billion
Dec. 31, 2025 19.6 billion 9.9 billion
Sept. 30, 2025 19.3 billion 9.7 billion
June 30, 2025 18.3 billion 8.8 billion

RPRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 760.5 million 122.0 million
Dec. 31, 2025 827.1 million 125.8 million
Sept. 30, 2025 702.6 million 72.8 million
June 30, 2025 364.0 million 90.8 million

RPRX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 294.7 million
Dec. 31, 2025 355.9 million
Sept. 30, 2025 444.2 million
June 30, 2025 90.6 million

RPRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 608.3 million 8.6 billion -
Dec. 31, 2025 637.5 million 8.6 billion 16.1 million
Sept. 30, 2025 955.0 million 8.6 billion 20.0 million
June 30, 2025 1.5 billion 7.0 billion -

RPRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 559.6 million
Dec. 31, 2025 559.6 million
Sept. 30, 2025 559.6 million
June 30, 2025 562.3 million

RPRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 40.0 million 159.0 million -
Dec. 31, 2025 - 51.0 million 164.3 million -
Sept. 30, 2025 1.1 million 50.5 million 118.7 million -
June 30, 2025 - 300.5 million 179.8 million -

RPRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 630.6 million 1.2 million
Dec. 31, 2025 622.0 million 1.2 million
Sept. 30, 2025 609.3 million 1.3 million
June 30, 2025 578.7 million 203.9 million

RPRX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

RPRX

List: Challengers

Price: $54.60

52 week price:
33.37
56.07

Dividend Yield: 1.66%

5-year range yield:
1.51%
3.00%

Forward Dividend Yield: 1.71%

Payout Ratio: 56.00%

Payout Ratio Range:
-18.46%
1963.27%

Dividend Per Share: 0.94 USD

Earnings Per Share: 1.90 USD

P/E Ratio: 27.18

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -16.0 million

Market Capitalization: 23.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 7

DGR3: 6.11%

Links: